Cancer immunotherapy in patients with brain metastases Salvatore CaponnettoArianna DraghiMarco Donia Review 08 March 2018 Pages: 703 - 711
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis Tao JiangMeng QiaoCaicun Zhou Original Article 08 February 2018 Pages: 713 - 727
Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node Jonathan R. McDanielStephanie C. PeroDavid N. Krag Original Article 09 February 2018 Pages: 729 - 738
Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation Shimrit Ringelstein-HarlevIrit AviviTami Katz Original Article 15 February 2018 Pages: 739 - 748
Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression Albert T. GacerezCasey K. HuaCharles L. Sentman Original Article 16 February 2018 Pages: 749 - 759
TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors Sumit MukherjeeRahman HussainiProbal Banerjee Original Article 16 February 2018 Pages: 761 - 774
The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells Daniela DörfelChristian J. LechnerSusanne M. Rittig Original Article 21 February 2018 Pages: 775 - 783
Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model Urska KamensekMaja CemazarGregor Sersa Original Article Open access 21 February 2018 Pages: 785 - 795
Certain BCG-reactive responses are associated with bladder cancer prognosis Guang ShanTian TangYue Xia Original Article 24 February 2018 Pages: 797 - 803
PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma Vinod VarkiOlga B. IoffeDan P. Zandberg Original Article 27 February 2018 Pages: 805 - 814
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models Heinz LäubliPhilipp MüllerAlfred Zippelius Original Article 27 February 2018 Pages: 815 - 824
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders Katharina C. KählerThomas K. EigentlerFor the German Dermatologic Cooperative Oncology Group (DeCOG) Original Article 27 February 2018 Pages: 825 - 834
Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens James A. KoziolHaruhiko ImaiEng M. Tan Original Article 01 March 2018 Pages: 835 - 841
Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy Aglaia DomouchtsidouVahé BarsegianMonika Lindemann Original Article 02 March 2018 Pages: 843 - 853
The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12–13, 2017, Royal Society, London, UK Angus G Dalgleish Meeting Report Open access 02 March 2018 Pages: 855 - 860